Australia with low COVID-19 numbers is in no hurry to reopen borders

Pfizer-BioNTech Vaccine Vakcina Oltás Coronavirus Koronavírus

Photo: MTI/Rosta Tibor

Australia is in no hurry to reopen its international borders and risk the country’s nearly coronavirus-free lifestyle, Prime Minister Scott Morrison said on Sunday.

Australia closed its borders to all non-citizens and non-residents in March 2020 and has been permitting only limited international arrivals in recent months, mainly its citizens returning from abroad.

The border closure, together with snap lockdowns, swift contact tracking and high community compliance with health measures, have made Australia one of the world’s most successful countries in curbing the pandemic, limiting coronavirus cases to under 29,500 infections and 910 deaths.

“Australia is in no hurry to open those borders, I assure you,” Morrison said at a televised briefing.

“I will not be putting at risk the way we are living in this country which is so different to the rest of the world today.”

For months now, except for some short snap lockdowns, Australians have been able to dine out, gather nearly freely and stop wearing face masks in most places.

They exchanged their international forays for local trips, with government figures showing big annual increases in intra-state travel in the first months of 2021.

From Monday, Australians and neighbouring New Zealanders will be able to travel between both countries without the need to apply for an exemption or spend time in mandatory quarantine.

New Zealand has had only 2,239 confirmed coronavirus cases and 26 related deaths.

Morrison flagged on Sunday that vaccinated Australians could be able travel overseas “for essential purposes” and return via home quarantine in the second half of the year, but that possibility is only in “planning stages”.

Australia recently abandoned a goal to vaccinate nearly all of its 26 million population by the end of 2021 following advice that people under the age of 50 take Pfizer’s COVID-19 vaccine rather than AstraZeneca’s shot.